AGP Executive Report
Last update: an hour agoRural Health Funding: Michigan’s first wave of $173M in federal rural healthcare grants is rolling out, but stakeholders are questioning whether the money is reaching the highest-need groups and calling for clearer reporting. Rural Access & Workforce: Separate coverage highlights how states are trying to shore up rural care capacity—through workforce prep, home-based services, and tech upgrades—amid ongoing federal cuts. New Trial for Long COVID: PridCor’s SHIELD phase 2 trial is moving from planning to enrollment, testing a combo antiviral approach to reduce long COVID fatigue, cognitive, and autonomic symptoms. Cardiovascular Prevention in Primary Care: Clinicians are urged to look for atrial fibrillation even when patients have no symptoms, with hypertension and sleep apnea flagged as key modifiable drivers. Regulatory & Product Updates: FDA clears a hydrogel spacer for prostate radiotherapy, and approves once-weekly basal insulin for adults with type 2 diabetes. Cancer Pipeline Signals: Multiple studies report advances across lung, myeloma, lymphoma, and cholangiocarcinoma, including new survival and response data plus device and biomarker progress. Public Health Watch: Measles outbreaks are expanding in the US, with Pennsylvania cited as a growing hotspot.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
